JOURNAL DE MYCOLOGIE MEDICALE, cilt.17, sa.1, ss.16-20, 2007 (SCI-Expanded)
Objective: Voricanozole and caspofungin are new antifungal agents used in the treatment of Candida infections. However, the susceptibility of Condida species to these antifungal agents could be variable. The aim of this study was to investigate the distribution of the Candida species isolated from hospitalized patients and to determine their susceptibilities to some antifungal agents including voriconazote, caspofungin, fluconazole and amphotericin B.